Can the world find a good covid-19 vaccine quickly enough?
And can it mass-produce it fairly if it does?
Editor’s note: The Economist is making some of its most important coverage of the covid-19 pandemic freely available to readers of The Economist Today, our daily newsletter. To receive it, register here. For our coronavirus tracker and more coverage, see our hub
THE EBOLA outbreak which began in 2013 was the largest the world has ever seen; over three years it killed more than 11,000 people in Guinea, Liberia and Sierra Leone. It also saw the first human trials of a vaccine against the disease.
This article appeared in the Briefing section of the print edition under the headline "So many possibilities, so little time"
From the April 18th 2020 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Briefing
America’s fiscal outlook is disastrous, but forgotten
On the campaign trail, both main candidates largely ignore the problem
America’s $61bn aid package buys Ukraine time
It must use it wisely
America is uniquely ill-suited to handle a falling population
Which is a worry, because much of it is already shrinking